Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study.

Anne-Claire Billet Thomas Barba Frédéric CoutantNicole FabienLaurent PerardPascal SèveJean-Christophe LegaCécile-Audrey DurelLaure GallayArnaud Hot

Published in: Biomedicines (2022)

Patients with DM-MDA5+ have an increased infection risk compared to others inflammatory myopathies irrespective of immunosuppressive therapy exposure. These results highlight the importance of monitoring for infection during patient follow-up.

Keyphrases

breast cancer cells
oxidative stress
type diabetes
interstitial lung disease
case report
mesenchymal stem cells
metabolic syndrome
cell proliferation
systemic sclerosis
insulin resistance
cell therapy
breast cancer risk